Dabur India Limited. Investor Communication. Quarter and Half Year ended September 30, 2014

Similar documents
Investor Communication. Quarter and Half Year ended 30 th September, 2016

Dabur India Limited Investor Communication

Dabur India Limited. Investor Communication. Quarter ended 30 th June August 4, 2017

Investor Presentation February 2016

Dabur India Ltd. Q3FY18 Result Update Strong Volume led Domestic growth; IBD remains weak. Sector: FMCG CMP: ` 356. Recommendation: BUY

Dabur India. CMP: INR130 TP: INR135 Neutral

Dabur India. Result Update Q3 FY15. Dabur matched our expectations by recording modest 9.2% yoy revenue

Dabur India. CMP: INR106 TP: INR94 Neutral

Dabur India Limited Investor Presentation CLSA India Forum November 2018

Dabur India. Share gains power growth, Accumulate. Source: Company Data; PL Research

Dabur India. Steady recovery in place; Accumulate. Source: Company Data; PL Research

Dabur India. Neutral. Rs93

DABUR Healthy and juicy

Dabur India Limited. Investor Presentation June 2018

Dabur. Bargain hunting BUY COMPANY UPDATE 12 DEC CMP (as on 12 Dec 2013) Rs 168 Target Price Rs 192

DABUR Going from strength to strength

DABUR INDIA LTD Result Update (CONSOLIDATED BASIS): Q3 FY19

Dabur India (DABIND) 355

Dabur India. Source: Company Data; PL Research

Dabur India Limited. Investor Presentation November December 2018

Dabur India. Institutional Equities. 1QFY19 Result Update

Results SQ 10. October 26, Investor Presentation

Dabur India (DABIND) 276

Dabur India. Worst is over; Accumulate. Source: Company Data; PL Research

Dabur India (DABIND) 290

Dabur India (DABIND) 287

Dabur India (DABIND) 275

Hindustan Unilever Limited. SQ 18 Results Presentation : 12 th October 2018

Hindustan Unilever Ltd.

Marico. Source: Company Data; PL Research

SQ 14 Results Presentation October 27, 2014

RESULTS FOR THE QUARTER ENDING 31 st MARCH % COMPARABLE* DOMESTIC CONSUMER GROWTH, 11% UNDERLYING VOLUME GROWTH

Dabur India (DABIND) 304

DQ 14 Results Presentation January 19, 2015

PDF processed with CutePDF evaluation edition

KRBL LIMITED. Investor Communication

PRESS RELEASE. Mumbai, January 27, 2016: Godrej Consumer Products Limited (GCPL), a leading

Hindustan Unilever. Q1FY19 Result Update Maintaining strong volume trajectory on high base is the key. Sector: FMCG CMP: ` 1,644. Recommendation: HOLD

DABUR INDIA LIMITED Half Yearly Financial Report A Fresh Outlook

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Dabur India Limited Annual Report Health is Wellth

Stock Update ITC. Cigarette sales disappoint; Non-cigarette FMCG outperforms. Reco: Hold CMP: Rs269

Q2FY18 Performance Review 25 th October 2017

Narnolia Securities Ltd. RAJEEV ANAND 15-Jan-18

Recovery to be gradual; Maintain HOLD

Colgate-Palmolive. Q1FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,083. Recommendation: HOLD

S H Kelkar and Company Limited

Narnolia Securities Ltd. RAJEEV ANAND 16-Oct-17

INDIA DAILY August 2, 2018 India 1-Aug 1-day 1-mo 3-mo

Investor Update 2 nd February 2019, Hyderabad

Performance Update - 4Q FY18 May 8, 2018

DABUR INDIA LIMITED RESEARCH

Times. Dabur India Limited Annual Report PDF processed with CutePDF evaluation edition

BUY. Big beneficiary of rural recovery; BUY DABUR INDIA. Target Price: Rs 395. Key drivers (%) FY18E FY19E FY20E

RESULTS FOR THE QUARTER ENDING 30 st JUNE % COMPARABLE* DOMESTIC CONSUMER GROWTH, 12% UNDERLYING VOLUME GROWTH

Uncommon sense. April 2009

DQ 2015 Results Presentation January 15, 2016

HUL. Q4FY17 Result Update Healthy performance, rich valuations. Sector: FMCG CMP: ` Recommendation: Hold

FUTURE RETAIL LIMITED

ITC. Q1FY17 Result Update Healthy Operational Performance; Maintain BUY. Sector: FMCG CMP: ` 251. Recommendation: BUY

Hindustan Unilever Limited. MQ 18 & FY Results Presentation : 14 th May 2018

DABUR INDIA LIMITED. Celebrating. Years of. Health & Well Being. Half Yearly Financial Report

Religare Investment Call

Godrej Consumer Products

Colgate-Palmolive. Q2FY18 Result Update Volume pressure continues; Soft A&P aids Margin. Sector: FMCG CMP: ` 1,063. Recommendation: HOLD

Q3FY15 at Rs.1382crore. 9MFY15 at Rs.3321crore. Q3FY15 at Rs.347 crore. 9MFY15 at Rs.371crore.

Financials/Valu FY15 FY16 FY17 FY18E FY19E. Almond Drops Hair Oil (ADHO) volume declined by 7% YoY and 120 BAJAJCORP NIFTY

Q1FY18 FINANCIALS JULY 27, 2017

JQ 14 Results Presentation July 28, 2014

CHANGE IN STANCE DABUR IN EQUITY June 13, 2017

Performance Update - 4Q FY16 May 3, 2016

September Quarter 2015 Results Presentation October 14, 2015

MQ 2015 & FY Results Presentation May 8, 2015

GODREJ CONSUMER PRODUCTS LIMITED 1Q FY2016 PERFORMANCE UPDATE

APL APOLLO TUBES LTD.

DABUR Volumes in revival mode; GST key monitorable

INVESTOR COMMUNICATION Q2FY18 & H1FY18

RESULTS FOR SEPTEMBER QUARTER % DOMESTIC CONSUMER SALES GROWTH, OPERATING PROFIT (PBIT) UP 11% IN SEPTEMBER QUARTER 2013

Osotspa Public Company Limited

Q2FY15 at Rs.948 crore. H1FY15 at Rs.1939 crore. Q2FY15 at Rs.3 crore. H1FY15 at Rs. 23 crore.

Britvic plc. Interims presentation 2015

Religare Investment Call

Thursday, May THE YEAR ENDED 31. Consolidated EBITDA. (Normalized for. year. previous year). year. the previous year. year. year.

DABUR INDIA LIMITED HALF YEARLY FINANCIAL REPORT

DABUR INDIA LIMITED. Half Yearly Financial Report

Sales EBITDA EBITDA PAT KEY INDICATORS. before R&D. Q2FY19 : Rs.1,125 crore vs Rs.1,022 crore in PY. H1FY19 : Rs.2,133 crore vs Rs.

Colgate-Palmolive. Q3FY17 Result Update Steep decline in Sales; EBITDA margin contraction continues. Sector: FMCG CMP: ` 879. Recommendation: HOLD

FY18 : Rs. 3,937 crore vs Rs 4,015 crore in PY. Q4FY18 : Rs. 47 crore vs Rs (87) crore in PY. Q4FY18 : Rs. (30) crore vs Rs (177) crore in PY

PRESS RELEASE. de-stocking; consolidated net profit without exceptional items is INR 230 crore

TTK Prestige. Q2FY18 Result Update Healthy Sales growth; Margins expands. Sector: Consumer Durable CMP: ` 6,145. Recommendation: HOLD

SOMANY CERAMICS LIMITED Q2/HY1 FY15 Investor Update. October 2014

Hindustan Unilever Limited SQ 17 Results Presentation : 25 th Oct 2017

August A Research Report On. By Islami Tijara Research Team. Copyright Reserved

TV Today Network BUY. Performance Update. CMP Target Price `315 `385. 2QFY2017 Result Update Media. Historical share price chart.

Firstsource Solutions Limited Q4 and FY2018 Earnings Update

FMCG. Equity Research INDIA. Downgrade HUL; prefer Dabur. Reason for report: Sector update. April 6, 2016 BSE Sensex: 24884

PEER GROUPS CMP MARKET CAP EPS P/E (X) P/BV(X) DIVIDEND Company Name (Rs.) Rs. in mn. (Rs.) Ratio Ratio (%)

Interim results FOR THE six months ENDED 30 September 2011

Half Year 2016 Results Presentation

Summary of Consolidated Business Results for the Three Months Ended June 30, 2011

Transcription:

Dabur India Limited Investor Communication Quarter and Half Year ended September 30, 2014 November 3, 2014

Performance Overview : Q2 FY2014-15 Consolidated Sales Consolidated EBITDA EBITDA Margins Consolidated PAT Grew by 10.4% to 1924.1crs Growth on Constant Currency basis is 11.8% Increased to Rs.389.7crs growing by 10.8% Stable at 20.3% in Q2FY15 v/s 20.2% in Q2FY14 Reported an increase of 15.1% to Rs. 287.5 crs 2

Financial Performance: Q2 FY15 Revenue (In Rs.Crs) 1,743.5 1,924.1 Q2FY14 Q2FY15 10.4%1 Consolidated sales grew by 10.4% with constant currency growth of 11.8% Domestic FMCG Business reported growth of 13.8% driven by volume growth of 8.7% 351.8 389.7 EBITDA margin was stable at 20.3% v/s 20.2% in Q2FY14 EBITDA (In Rs.Crs) 10.8%1 Material Costs were higher at 47% of sales in Q2FY15 vs 46.3%in Q2FY14 Q2FY14 Q2FY15 Adpro expenses were stable at 13.2% of sales *PAT (In Rs.Crs) *After minority interest 249.7 287.5 Q2FY14 Q2FY15 15.1%1 PAT grew by 15.1% with PAT margins increasing by 62bps. Lower finance cost and lower effective tax rate added to growth in PAT 3

Financial Performance: H1 FY15 Revenue (In Rs.Crs) 3,390.5 3,788.0 H1FY14 H1FY15 11.7%1 Consolidated sales grew by 11.7% with constant currency growth of 11.6% Domestic FMCG Business reported growth of 13.2% driven by volume growth of 8.6% EBITDA (In Rs.Crs) 622.6 693.7 11.4%1 EBITDA margin was stable at 16.3% v/s 16.4% in H1FY14, inspite of higher material costs H1FY14 H1FY15 435.7 498.3 PAT grew by 14.4% in H1FY15 *PAT (In Rs.Crs) 14.4%1 PAT margins increased from 12.9% in H1FY14 to 13.2% in H1FY15 *After minority interest H1FY14 H1FY15 4

Steady Volume Growth Dabur Domestic FMCG Volume Growth % 11.6% 9.0% 9.5% 12.3% 9.0% 10.7% 9.0% 9.2% 8.3% 8.7% Q1FY13 Q2FY13 Q3FY13 Q4FY13 Q1FY14 Q2FY14 Q3FY14 Q4FY14 Q1FY15 Q2FY15 Robust Volume growth trend in Dabur sales over last 10 quarters 5

Business Overview Q2 FY15 Sales Contribution* Q2FY15 Domestic Business- Category Breakup Skin Care 5% Q2 FY15 Foods 19% Health Supplements 16% Digestives 6% International 34% Domestic 66% Oral Care 15% Hair Care 23% OTC & Ethicals 9% Domestic and International Sales Growth Rates 13.8% Domestic FMCG 8.3% International Home Care 7% International Business contributed to 34% of consolidated sales Domestic FMCG business reported growth of 13.8% International Business grew by 8.3% in Constant Currency terms Note: International growth is in Constant Currency & includes Namaste & Hobby * Excludes Retail 6

Business Overview H1 FY15 Sales Contribution* H1FY15 H1 FY15 International 34% Domestic 66% Domestic Business- Category Breakup Skin Care 5% Foods 21% Oral Care 14% Health Supplements 15% Hair Care 24% Digestives 6% OTC & Ethicals 9% Home Care 6% Domestic and International Sales Growth Rates 13.2% Domestic FMCG 11.6% International International Business contributed to 34% of consolidated sales Domestic FMCG business reported growth of 13.2% International Business grew by 11.6% in Constant Currency terms Note: International growth is in Constant Currency & includes Namaste & Hobby * Excludes Retail 7

Consumer Care Business Consumer Care Category Growth Rates (%) 15.0% 13.9% 10.1% 12.3% 11.8% 11.0% 10.2% 12.2% 9.7% 7.5% 6.1% 8.1% 8.1% 6.9% Q2FY15 H1FY15 Health Supplements Digestives OTC & Ethicals Hair Care Home Care ORAL CARE Skin Personal care segments reported improvement in growth rates over previous quarters Most Categories grew strongly ahead of market growth driven by sustained Adpro investments 8

Health Supplements & Digestives Health Supplements * * Growth 10.1% Growth 12.3% Digestives Reported moderate growth in Q2FY15 on account of extended summers Focus on Variant Extensions Ratnaprash to be launched nationally Glucose Reported double digit growth in Q2FY15 driven by strong volume led momentum Good performance with mid teens growth Weight Management proposition working well for the brand *Growth refers to Q2FY15 New variants - Hajmola Chuzkara & Amrud have elicited a good response Consumer Activation & aggressive Digital marketing resulted in reaching 30 million new consumers 9

*Growth refers to Q2FY15 OTC & Ethicals 10 OTC & Ethicals * Growth 7.5 % Ethicals reported stong mid teens growth driven by on the ground activities, digital initiatives and doctor connect Lal Tail had subdued performance during the Quarter. New campaign was launched which received good response and 1.5 lac views on Youtube OTC Strategy Building Advocacy through Consumer Activations and infomercials Uplift imagery to appeal to consumers Focus on media to push consumer demand Honitus Franchise did reasonably well this quarter - positioning Honitus as Non drowsy cough and cold expert OTC category was sluggish due to late onset of monsoons.

Building Equity in Ayurveda 11

Hair Care Hair Care Growth 13.9% Hair Oils reported good growth with both coconut & perfumed Hair Oils performing well Amla Hair Oil relaunched with a new flip top pack endorsed by two celebrities, Priyanka Chopra and Sonakshi Sinha Shampoo portfolio performed well with double digit growth which was largely volume led *Growth refers to Q2FY15 12

HomeCare Home Care Growth 10.2% Recorded good growth this Quarter Posted high teens growth in Q2FY15 Joining Prime Minister Narendra Modi s call for his Swachh Bharat Mission, a cleanliness drive took place across public conveniences of Sulabh International using Sanifresh Sales were impacted to some extent by delayed monsoons Odomos Wrist band and Patches, launched in Q2FY15 have been co-branded with Chhota Bheem and are doing well *Growth refers to Q2FY15 13

Skin Care Skin Care Growth 10% Fem Bleaches reported double digit growth in Q2FY15 Sustained investment in Advertising & Promotion Fem Star Contest drew good response from consumers Focus on more contemporary offerings & drive relevance of the product by strengthening Rose association with beauty Promotion Activities *Growth refers to Q2FY15 14

Oral Care Oral Care Growth 8.1% Toothpaste grew by 11.5% in Q2FY15 Continued on a robust growth trajectory and recorded strong double digit growth Growth was largely volume led with gains in market share Brand continued to be under pressure with LUPs reporting muted growth Focus on Improving Imagery parameters to drive brand Equity Reported strong double digit growth in Q2FY15 Expand in existing geographies with an Urban focus *Growth refers to Q2FY15 15

Foods Foods Growth 29% Real Fruit Juices performed exceedingly well across channels & regions and registered strong double digit growth The Cheer a child campaign of Real Greetings helped strengthen the Dil Se Dua positioning Aim to collect as many number of missed calls and Likes on facebook/twitter as possible; and Real donated equivalent number of juice packs to underprivileged children of PRAYAS an NGO Continued to perform well and posted robust double digit growth *Growth refers to Q2FY15 16

International Business International Business registered growth of 8.3% in Q2FY15 on constant currency basis Organic International Business grew by 17.5% in constant currency driven by good growth in GCC, Egypt and Turkey markets Namaste business was under pressure due to category slowdown in the US and high base in non US markets Focus continues on aggressive NPDs in MENA region Manufacturing unit in Tunisia unit commenced commercial production Key Growth Markets Q2 FY15 (%) 35% 30% 25% 20% 15% 10% 5% 0% 24% 28% 32% 27% GCC Egypt Turkey Levant Note: Above growths are in constant currency terms 17

Dabur International- Brand Architecture 18

Continued Focus on Innovations India Amla Hair Oil- Innovative packaging ( Flip top pack) Odomos Wrist Band & Patches Intl. Hobby Trendz Hair Gel Hajmola Hing variant Vatika Genghir Hair Oil Vatika Enriched Sarson Hair Oil 19

Leveraging Digital Media Community of Chatpata content on Facebook and Twitter Honey Recipes on Youtube Yahoo Page Takeover- Amla Hair Oil Fem Promotion using Facebook- Upload your picture and wishes and come live on TV 20

Interim Dividend Interim Dividend H1FY15 Dividend Per share (Rs.) 1.25 Dividend% 125% Total dividend(rs.crs)* 256.8 *Note: Includes dividend tax 21

Consolidated P&L DIL (Consolidated) P&L - in Rs. crores Q2FY15 Q2FY14 YoY (%) H1FY15 H1FY14 YoY (%) Net Sales 1,924.1 1,743.5 10.4% 3,788.0 3,390.5 11.7% Other Operating Income 5.5 5.4 1.6% 10.4 10.8-3.5% Material Cost 903.4 807.2 11.9% 1826.0 1614.5 13.1% % of Sales 47.0% 46.3% 48.2% 47.6% Employee Expense 182.5 158.8 14.9% 339.4 296.8 14.4% % of Sales 9.5% 9.1% 9.0% 8.8% Advertising & Publicity 253.3 227.4 11.4% 539.6 481.7 12.0% % of Sales 13.2% 13.0% 14.2% 14.2% Other Expenses 239.5 226.2 5.9% 474.5 441.4 7.5% % of Sales 12.4% 13.0% 12.5% 13.0% Other Non Operating Income 38.9 22.6 72.1% 74.8 55.7 34.3% EBITDA 389.7 351.8 10.8% 693.7 622.6 11.4% % of Sales 20.3% 20.2% 18.3% 18.4% Finance Costs 10.2 20.0-49.0% 20.3 33.3-39.0% Depreciation & Amortization 29.2 23.6 23.8% 55.9 45.6 22.6% Profit Before Tax (PBT) 350.3 308.3 13.6% 617.5 543.7 13.6% Exceptional Item 0.0 0.0 0.0 0.0 Tax Expenses 61.6 57.9 6.4% 117.6 106.3 10.6% Provision for Taxation for Earlier years PAT(Before extraordinary item) 288.8 250.4 15.3% 499.9 437.4 14.3% % of Sales 15.0% 14.4% 13.2% 12.9% Extraordinary Item 0.0-0.1-100.0% 0.0-0.1 PAT(After extraordinary Items) 288.8 250.3 15.4% 499.9 437.4 14.3% Minority Interest - Profit/(Loss) 1.3 0.6 1.6 1.6 PAT (After Extra ordinary item & Minority Int) 287.5 249.7 15.1% 498.3 435.7 14.4% % of Sales 14.9% 14.3% 13.2% 12.9% 22

Statement of Assets & Liabilities- Consol Particulars As at 30/09/2014 (Audited) As at 31/03/2014 (Audited) Â EQUITY AND LIABILITIES 1 Shareholders funds (a) Share capital 175.64 174.38 (b) Reserves and surplus 2797.34 2481.58 Sub-total - Shareholders' funds 2972.98 2655.96 2. Minority interest 17.48 15.91 3. Non-current liabilities (a) Long-term borrowings 300.02 260.40 (b) Deferred tax liabilities (net) 54.55 44.83 (c) Long-term provisions 45.11 40.89 Sub-total - Non-current liabilities 399.68 346.12 4. Current liabilities (a) Short-term borrowings 330.80 447.74 (b) Trade payables 1013.73 1096.53 (c )Other current liabilities 510.20 479.42 (d) Short-term provisions 88.01 270.10 Sub-total - Current liabilities 1942.74 2293.79 TOTAL - EQUITY AND LIABILITIES 5332.88 5311.78 B ASSETS 1. Non-current assets (a) Fixed assets 1235.08 1167.21 (b) Goodwill on consolidation 621.40 621.40 (c) Non-current investments 619.16 512.72 (d) Long-term loans and advances 19.71 24.54 (e) Other non-current assets 18.15 18.07 Sub-total - Non-current assets 2513.50 2343.94 2 Current assets (a) Current investments 368.49 563.75 (b) Inventories 1081.74 972.29 (c) Trade receivables 694.26 675.30 (d) Cash and cash equivalents 354.45 519.38 (e) Short-term loans and advances 170.88 132.01 (f) Other current assets 149.56 105.11 Sub-total - Current assets 2819.38 2967.84 TOTAL - ASSETS 5332.88 5311.78 23

Thank You 24